Pembrolizumab in Hepatocellular carcinoma
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Jan 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.
- 15 Jan 2018 Status changed from not yet recruiting to recruiting.
- 26 May 2017 New trial record